Workday HRIS Lead
Accurate BackgroundSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Human Resources, Information TechnologyIndustries
Requirements
Candidates should possess a Bachelor’s degree in Computer Science, Information Systems, Human Resources, or a related field, and a minimum of 7 years of hands-on Workday configuration and solution delivery experience. They should also hold a Workday Pro or former Workday implementer certification, ideally in Payroll, Time Tracking, Absence, and Advanced Reporting, with additional certifications in Core HCM and Compensation being a plus. Furthermore, candidates must have experience supporting global Workday environments and understanding multi-country regulatory requirements.
Responsibilities
As a Principal HRIS Analyst, the role involves leading the design, configuration, and continuous improvement of Workday solutions for Payroll, Time Tracking, Absence, and Compensation, serving as a functional and technical subject matter expert, supporting cross-functional initiatives, driving continuous improvement, ensuring scalable configurations, owning Workday release management, advising stakeholders, managing work independently, collaborating across HR, IT, and business functions, and communicating effectively on timelines and outcomes.
Skills
Workday
Payroll
Time Tracking
Absence Management
Compensation
HCM
Reporting
Configuration
Release Management
Global Workday
Multi-Country Regulations
Moderna
Develops mRNA-based medicines for health
About Moderna
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.
Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees